Participated · Series C · Jul 2026

Antora Energy develops and deploys factory-built thermal batteries that store low-cost electricity as heat in insulated solid-carbon blocks and deliver that energy as heat or power on demand. The company says its systems can store energy for multiple days, avoid supply-constrained critical minerals, and be deployed faster than conventional multi-year projects. Antora recently brought one of the largest battery storage projects online—a 5 gigawatt-hour system in South Dakota that moved from construction to energy delivery in under 12 months—and expanded its San Jose factory into a three-building manufacturing campus. The company reports a growing pipeline of signed agreements with hyperscalers and industrial customers and states its deployments have created and supported hundreds of U.S. manufacturing and construction jobs. With the $550 million Series C, Antora plans to expand production capacity, establish a second U.S. manufacturing hub, and strengthen its domestic supply chain. The company positions its technology as a tool to deliver affordable, reliable energy at scale to industry, data centers, and the grid.

Participated · Series A · Jul 2026

Founded in 2024 by former SpaceX engineers Noah Schochet and Noah McGuinness, TerraFirma builds a full-stack platform that combines AI-enabled pre-construction software, a remote command-and-control center, and retrofitted semi-autonomous heavy machinery for earthworks and site operations. The company's systems let skilled operators orchestrate fleets from screens, which TerraFirma says can make each operator up to 300% more effective. TerraFirma is executing commercial projects including site preparation, excavation, and grading for a Starbucks in North Austin, a sports arena in Spicewood, and a power substation in New Braunfels, and it is working with the U.S. government on international infrastructure and logistics projects. The company is vertically integrated, building and using its own robotics and software in the field while keeping operators at the center. TerraFirma has stated a long-term ambition to extend its construction technology to lunar and Martian projects as well as scale on Earth. Financially, TerraFirma announced approximately $115 million in new capital, including a $100 million Series A, to expand engineering, manufacturing, operations, and continued development of its semi-autonomous equipment.

Participated · Series A · Jun 2026

Foundation Alloy commercializes a solid-state alloying technique that repeatedly smashes metal powders together to create homogeneous alloys that traditional melting processes cannot achieve. The process reportedly uses around an order of magnitude less energy than conventional melting-based alloying and enables combinations of elements with very different melting points. The company has been selling bespoke metals in small batches and is running pilots with customers in automotive, aerospace, semiconductor, defense, luxury watches, and cutlery. Early commercial products include tooling parts for automakers and parts targeted at drone supply chains within defense. Foundation Alloy says it is currently constrained by production capacity rather than demand and plans to scale to several tons per week by 2027 using proceeds from its Series A. Its technology builds on about 20 years of research led by Tim Rupert and Chris Schuh, and the company is led by CEO and co-founder Jake Guglin.

Participated · Series A · Jun 2026

Neion Bio’s core product is the Raptor™ platform, which leverages genetic engineering to restrict recombinant protein production to chicken eggs as a means to manufacture complex, glycosylated biologic proteins. Founded in 2024, the company is positioning the platform to address scalability, resiliency, capital efficiency, speed, and the ability to express difficult-to-manufacture molecules. Neion plans to expand its pipeline across biosimilars, innovative medicines, critical reagents, and animal health and to commercialize via partnerships, including a recently announced multi-product biosimilars co-development and supply agreement with a major pharmaceutical company. The company is advancing proprietary technologies intended to enable production at meaningful scale within days and to shorten iteration cycles for molecule screening and production. Financially, Neion completed an oversubscribed $23 million Series A to fund these platform and pipeline initiatives.

Participated · Series A · Dec 2025

Truemed operates a technology platform and marketplace that connects consumers, clinicians, and merchants to enable Health Savings Account (HSA) and Flexible Spending Account (FSA) payments for lifestyle and preventive health interventions. Its compliance workflow secures letters of medical necessity through functional-medicine clinicians, allowing qualified users to pay for products and services from thousands of partners such as Peloton, Eight Sleep, Nike Strength, and 24 Hour Fitness. The company targets conditions like early heart disease, mental health issues, chronic pain, and metabolic disorders. Management reports 3× year-over-year revenue growth for each of the past two years, underscoring rapid commercial traction. Truemed positions itself as a shift from reactive “sick care” to proactive health management by aligning financial incentives with healthy behaviors. The newly raised capital will go toward expanding the product suite, broadening the merchant portfolio, and boosting consumer awareness of HSA/FSA eligibility for preventive care.